Stage IIIC Esophageal Cancer AJCC v7 Active Not Recruiting Phase 1 Trials for Ganetespib (DB12047)

IndicationStatusPhase
DBCOND0088905 (Stage IIIC Esophageal Cancer AJCC v7)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02389751Ganetespib in Combination With Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-III Esophageal CancerTreatment